Caponex Labs Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.99 Cr
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 19.88 Cr
- Revenue Growth 959.12%
- Profit Growth -124.84%
- Ebitda 679.32%
- Net Worth 48.67%
- Total Assets 16.49%
About Caponex Labs
Caponex Labs Private Limited (CLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 August 2020 (Four years and six months 16 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.99 Cr.
The company currently has active open charges totaling ₹19.88 Cr.
Srinivasa Madireddy and Deepika Madireddy serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100TG2020PTC142637
- Company No.
142637
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Caponex Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivasa Madireddy  | Director | 08-Aug-2020 | Current |
| Deepika Madireddy | Director | 08-Aug-2020 | Current |
Financial Performance of Caponex Labs.
Caponex Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 959.12% increase. The company also saw a substantial fall in profitability, with a 124.84% decrease in profit. The company's net worth Soared by an impressive increase of 48.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Caponex Labs?
In 2023, Caponex Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mothercell Biosciences Private LimitedSrinivasa Madireddy and Deepika Madireddy are mutual person
Charges (Loans)
₹19.88 Cr
₹0
Charges Breakdown by Lending Institutions
- Indian Bank : 19.88 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 2021 | Indian Bank | ₹19.88 Cr | Open |
How Many Employees Work at Caponex Labs?
Caponex Labs has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caponex Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caponex Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.